Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Health
GLP-1s could end up being ‘the first true longevity drug’ as the world battles a rising obesity crisis
By
Angelica Ang
November 21, 2025
Newsletters
Why big pharma is teaming up with AI giants to speed up drug discovery and make work easier for health care workers
By
John Kell
November 19, 2025
Economy
Novo Nordisk CFO outlines ‘ultimate defense’ against stock downgrades and lawsuits to retain weight-loss crown
By
Eleanor Pringle
November 6, 2025
Workplace Culture
How pharma giant AbbVie holds leaders accountable for culture
By
Ted Kitterman
and
Great Place To Work
October 9, 2025
North America
Mark Cuban says Trump’s new drug platform could succeed if it forces pharma managers to change: ‘If that happens, Trump gets all the credit’
By
Sasha Rogelberg
October 2, 2025
Success
Mark Cuban says his best investment of all time was still living like a student after college—including sleeping on the floor and driving a $200 broken car
By
Jessica Coacci
September 29, 2025
Economy
All bark, no bite: Trump’s latest trade war turns into another TACO salad for Wall Street
By
Eva Roytburg
September 26, 2025
Investing
Trump’s overnight demand for 100% tariffs on pharmaceuticals will be ‘a meaningful commercial hit for U.S. consumers,’ top analyst says
By
Jim Edwards
September 26, 2025
Health
Scientists rebuke Trump’s Tylenol-autism claim, stress fever is bigger danger in pregnancy
By
Jason Gale
and
Bloomberg
September 23, 2025
North America
Swiss drug giant looks for ways to lower U.S. prices amid tariff threat and admits Americans ‘pay for a large part of the innovations’
By
AFP
September 20, 2025
Innovation
The AI drug breakthrough is taking a long time to arrive for reasons that may have little to do with the technology’s limits
By
Sasha Rogelberg
September 12, 2025
Commentary
A new era of access demands smarter design for direct-to-consumer drug pricing
By
Wendy Barnes
September 5, 2025
Commentary
AI might beat IQ, not EQ — but never say never
By
Paul Hudson
September 2, 2025
Politics
Trump’s plan for hefty tax on imported drugs risks higher prices and shortages
By
Paul Wiseman
,
Tom Murphy
and
The Associated Press
September 1, 2025
Health
Novo Nordisk slashes price of Ozempic in half to $499 for cash-paying, eligible U.S. patients
By
Nick Lichtenberg
August 18, 2025
Most Popular
Retail
Trump just declared Christmas Eve a national holiday. Here’s what’s open and closed
By
Dave Smith
Personal Finance
Trump turns government into giant debt collector with threat to garnish wages on millions of Americans in default on...
By
Annie Ma
and
The Associated Press
Personal Finance
Financial experts warn future winner of the $1.7 billion Powerball: Don't make these common money mistakes
By
Ashley Lutz